Hemogenyx Pharmaceuticals (UK) Probability of Future Stock Price Finishing Under 538.0

HEMO Stock   387.50  12.50  3.12%   
Hemogenyx Pharmaceuticals' future price is the expected price of Hemogenyx Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Hemogenyx Pharmaceuticals PLC performance during a given time horizon utilizing its historical volatility. Check out Hemogenyx Pharmaceuticals Backtesting, Hemogenyx Pharmaceuticals Valuation, Hemogenyx Pharmaceuticals Correlation, Hemogenyx Pharmaceuticals Hype Analysis, Hemogenyx Pharmaceuticals Volatility, Hemogenyx Pharmaceuticals History as well as Hemogenyx Pharmaceuticals Performance.
  
Please specify Hemogenyx Pharmaceuticals' target price for which you would like Hemogenyx Pharmaceuticals odds to be computed.

Hemogenyx Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Hemogenyx Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Hemogenyx Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Hemogenyx Pharmaceuticals generated a negative expected return over the last 90 days
Hemogenyx Pharmaceuticals has high historical volatility and very poor performance
Net Loss for the year was (6.69 M) with profit before overhead, payroll, taxes, and interest of 0.
Hemogenyx Pharmaceuticals generates negative cash flow from operations

Hemogenyx Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Hemogenyx Stock often depends not only on the future outlook of the current and potential Hemogenyx Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hemogenyx Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.1 B
Cash And Short Term Investments1.2 M

Hemogenyx Pharmaceuticals Technical Analysis

Hemogenyx Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Hemogenyx Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Hemogenyx Pharmaceuticals PLC. In general, you should focus on analyzing Hemogenyx Stock price patterns and their correlations with different microeconomic environments and drivers.

Hemogenyx Pharmaceuticals Predictive Forecast Models

Hemogenyx Pharmaceuticals' time-series forecasting models is one of many Hemogenyx Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Hemogenyx Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Hemogenyx Pharmaceuticals

Checking the ongoing alerts about Hemogenyx Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Hemogenyx Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Hemogenyx Pharmaceuticals generated a negative expected return over the last 90 days
Hemogenyx Pharmaceuticals has high historical volatility and very poor performance
Net Loss for the year was (6.69 M) with profit before overhead, payroll, taxes, and interest of 0.
Hemogenyx Pharmaceuticals generates negative cash flow from operations

Additional Tools for Hemogenyx Stock Analysis

When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.